EXHIBIT A FEES AND SERVICES; AND CLIENT DUTIES

New Post Public Reply Private Reply Replies (0) Message Board
tc2000chartreader docj #21756
247
EXHIBIT A



FEES AND SERVICES; AND CLIENT DUTIES



A. Fees.
1. For the 1st year Term, NGH will provide an Invoice to Client every month with Patients processed and eligible for reimbursement. The invoiced amounts are to be as laid out in Exhibit B. per month for each complete Remote Patient Monitoring patient; and CCM patient. Thereafter, the pricing might be adjusted annually to reflect changes in policy.


B. Services.
1. Provide Client with a software suite, Bluetooth medical devices and associated services for CCS.
2. In collaboration with and assistance from NGH, Client will implement the NuGen SaaS suite on site at the Client’s clinic(s).
3. Provide necessary staff to perform the CCS services for Client’s patients.
4. Provide necessary training to Clients’ staff to ensure proper use of NGH’s products and services.
5. NGH will be responsible for providing FDA-cleared, CMS approved medical devices for Remote Patient Monitoring, technical assistance, device connection, and data reporting.
6. NGH will identify any patient threshold breeches so action can be taken in real time to avoid hospitalizations and gives the ability to direct care as appropriate.
7. NGH will seek improvement in patient medication compliance with the direct reminders (voice/text) for the patients to take their medications.
8. NGH will perform outbound calls and reviews of the patient’s health plan/care plan to direct, train and encourage compliance on medication, pain levels, and ensuring frequency of uploads of prescribed data such as glucose, blood pressure, weight, temperature, oxygen level, etc.
9. NGH will provide a dashboard provides the MA and the Physician with an easy to view, patient by patient, status as well as end of the month billing documentation.
10. NGH will provide a 24 hour call in number for emergencies.
11. NGH will provide manage oversight and continued software, hardware updates and improvements training and retraining of staff.
12. NGH will provide at the end of each billing period the documentation for Client to bill for the patients conforming to the set of standards required by CMS for reimbursement.
13. The parties agree to act in good faith to ensure success and will evaluate the reimbursements on a quarterly basis to assess any changes in reimbursement.
14. If PVFM requests customized or enhanced system designs or additional equipment, then NGH will bill at the scheduled rates in the IT support section below.


C. Client Duties.
1. Provide NGH’s Medical Assistants (MA’s) with desk space and computers to engage and register patients, coordinate connected patient care, and conduct the RPM and CCM patient service.
2. Client will be responsible for managing NGH medical device inventory located on site and will not allow devices to be given to non enrolled patients as well as replace any shortage at their expense.
3. Client agrees to sign a Business Associates Agreement (BAA) with NGH to comply with all HIPAA regulations.
4. Upon proof of concept and both parties agreement, Client shall integrate the eClinicalworks Electronic Health Record (EHR) with the NuGenHealth system for billing, data exchange, analytic analysis, and population health management to be conducted by NGH and shared with Client.
5. At the end of the collection period which shall be 30 days from the invoice received from NGH the Client will pay NGH in full for the invoice for the processed patients.
6. Client agrees to cooperate and comply with any and all audit requests by NGH’s auditors or other audits by any governmental agency as may be requested and/or required.

Generex Biotechnology Corp. (GNBTQ) Stock Research Links

GNBTQ Board Company Profile Buy Rating Time & Sales News Filings Financials
Disclaimer: Of course, all of this is my opinion and you should not make any investment decisions based on my opinion. I have not received any non-public information.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 11

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 11

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 7

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 7

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 12

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 5

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 8

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 12

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading
Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Updated Category News Views 12

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Continue Reading

Top 5 Most Recently Viewed Articles

Understanding ADHD and the Role of RELEXXII in Treatment

Updated Category News Views 215

Supporting ADHD Awareness: The Role of RELEXXII This month marks a significant time for acknowledging and educating people about Attention Deficit Hyperactivity Disorder (ADHD). Alora Pharmaceuticals, the leading manufacturer behind RELEXXII® (methylphenidate hydrochloride extended-release tablet), is deeply committed to this cause. ADHD impacts various dimensions of...

Continue Reading
New Class Action Filed Against Paragon 28 Over Alleged Fraud

Updated Category News Views 111

Introduction to the New Class Action Against Paragon 28 Hagens Berman has recently taken action by filing a class action lawsuit against Paragon 28, Inc. (NYSE: FNA) alongside several of its senior executives. The case aims to hold the company accountable for alleged fraudulent activities affecting investors. Overview of the Allegations The lawsuit extends an ongoing...

Continue Reading
Subway Teams Up with ARC Raiders for Gaming Promo

Updated Category News Views 16

What’s Cooking Between Subway and Embark Studios? Subway’s diving headfirst into the gaming world, folks. It’s not a piece of cake to see a sandwich giant team up with a game studio, but today, Subway’s sidestepping the typical food deal. Instead, it's sharpening its digital claws with Embark Studios, a Stockholm-based game developer. They’re gearing up for the...

Continue Reading
CagriSema Breakthrough: Weight Loss Success in Adults

Updated Category News Views 312

Significant Weight Loss Achieved with CagriSema in Clinical Trial In recent findings, Novo Nordisk has unveiled compelling results from the extensive REDEFINE 1 trial, focusing on the innovative weight loss treatment, CagriSema. This clinical study assessed the efficacy of subcutaneous CagriSema—a fixed-dose combination of cagrilintide 2.4 mg and semaglutide 2.4 mg—in...

Continue Reading
Endor Labs Achieves Remarkable Growth in Application Security

Updated Category News Views 390

Endor Labs Shows Impressive Revenue Growth Endor Labs, a leader in application security, proudly announces a significant milestone: a whopping 225% year-over-year revenue growth. This achievement highlights the increasing demand for robust security measures that can keep pace with the rapid transformations in software development, especially given the rise of AI...

Continue Reading